Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
489 An early phase expansion cohort study of fianlimab (a... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
489 An early phase expansion cohort study of fianlimab (anti–lymphocyte activation gene-3 [LAG-3]) plus cemiplimab (anti–programmed cell death-1 [PD-1]) in patients with advanced malignancies
0
Authors
Tae Kim
24 more
Tae Kim
•
Stephen Williamson
22 more
•
Byoung Cho
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Biology
Cancer Oncology
Chemistry
Medicine
Internal Medicine
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0489
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Biology
Cancer Oncology
Chemistry
Medicine
Internal Medicine
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0489
License
CC-BY-NC
Other Formats
PDF
